Biosig Technologies Stock Today

BSGM Stock  USD 1.41  0.13  8.44%   

Performance

3 of 100

 
Weak
 
Strong
Insignificant

Odds Of Distress

Less than 46

 
High
 
Low
About Average
Biosig Technologies is selling at 1.41 as of the 19th of April 2024; that is -8.44 percent decrease since the beginning of the trading day. The stock's lowest day price was 1.35. Biosig Technologies has 46 percent odds of going through some form of financial distress in the next two years and did not have a very good performance for investor during the last 90 trading days. Equity ratings for Biosig Technologies are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 20th of March 2024 and ending today, the 19th of April 2024. Click here to learn more.
Business Domain
Health Care Equipment & Services
IPO Date
30th of October 2014
Category
Healthcare
Classification
Health Care
BioSig Technologies, Inc., together with its subsidiaries, operates as medical device company. BioSig Technologies, Inc. was incorporated in 2009 and is headquartered in Westport, Connecticut. Biosig Technologies operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. The company has 11.2 M outstanding shares of which 694.94 K shares are currently shorted by private and institutional investors with about 2.37 trading days to cover. More on Biosig Technologies

Moving against Biosig Stock

  0.72VMD Viemed HealthcarePairCorr
  0.71FEMY Femasys Financial Report 9th of May 2024 PairCorr
  0.71BAX Baxter International Financial Report 25th of April 2024 PairCorr
  0.67ELMD ElectromedPairCorr
  0.54ALC Alcon AG Financial Report 14th of May 2024 PairCorr
  0.49CAH Cardinal Health Financial Report 2nd of May 2024 PairCorr
  0.48BDX Becton Dickinson Financial Report 2nd of May 2024 PairCorr
Follow Valuation Options Odds of Bankruptcy
Check how we calculate scores

Biosig Stock Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Biosig Technologies' investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Biosig Technologies or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
President CEO, DirectorGregory Cash
Business ConcentrationHealth Care Equipment & Supplies, Health Care Equipment & Services, Health Care, NASDAQ Composite, NASDAQ Health Care, Health Care, Health Care Equipment & Supplies, Medical Devices, Healthcare (View all Sectors)
Average Analyst Recommendation
Analysts covering Biosig Technologies report their recommendations after researching Biosig Technologies' financial statements, talking to executives and customers, or listening in on Biosig Technologies' conference calls. The current trade recommendation is based on an ongoing consensus estimate among financial analysts covering Biosig Technologies. The Biosig consensus assessment is calculated by taking the average forecast from all of the analysts covering Biosig Technologies.
Financial Strength
Based on the key indicators related to Biosig Technologies' liquidity, profitability, solvency, and operating efficiency, Biosig Technologies may be sliding down financialy. It has an above-average probability of going through some form of financial hardship next quarter. Financial strength of Biosig Technologies is based on its profitability, leverage, liquidity, source of funds, and operating efficiency.
Current ValueLast YearChange From Last Year 10 Year Trend
Asset Turnover0.00950.01
Notably Down
Very volatile
Gross Profit Margin0.540.72
Way Down
Slightly volatile
Total Current Liabilities3.2 M4.6 M
Way Down
Slightly volatile
Total Assets1.7 M1.8 M
Notably Down
Slightly volatile
Total Current Assets501.6 K528 K
Notably Down
Slightly volatile
Biosig Technologies' financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Biosig Technologies' success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit.
Financial leverage usually refers to the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Biosig Technologies' financial leverage. It provides some insight into what part of Biosig Technologies' total assets is financed by creditors.
By using current balance sheet information, investors can analyze the liability, assets, and equity on Biosig Technologies' books and decide whether to invest or hold. Statistics such as return on equity (ROE), debt to equity (D/E) help investors determine how Biosig Technologies deploys its capital and how much of that capital is borrowed.
Liquidity
Biosig Technologies cash flow analysis is essential to understand how it generates and spends money over a specific period. It can also help you figure out where your money is going and how much cash you have available at a given moment. The company currently holds 452 K in liabilities with Debt to Equity (D/E) ratio of 0.45, which is about average as compared to similar companies. Biosig Technologies has a current ratio of 1.2, suggesting that it is in a questionable position to pay out its financial obligations when due. Debt can assist Biosig Technologies until it has trouble settling it off, either with new capital or with free cash flow. So, Biosig Technologies' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Biosig Technologies sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Biosig to invest in growth at high rates of return. When we think about Biosig Technologies' use of debt, we should always consider it together with cash and equity.

Depreciation

379,050
Biosig Technologies (BSGM) is traded on NASDAQ Exchange in USA. It is located in 55 Greens Farms Road, Westport, CT, United States, 06880 and employs 47 people. Biosig Technologies is listed under Health Care Equipment & Supplies category by Fama And French industry classification. The company currently falls under 'Micro-Cap' category with a current market capitalization of 17.25 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Biosig Technologies's market, we take the total number of its shares issued and multiply it by Biosig Technologies's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Biosig Technologies conducts business under Health Care Equipment & Supplies sector and is part of Health Care industry. The entity has 11.2 M outstanding shares of which 694.94 K shares are currently shorted by private and institutional investors with about 2.37 trading days to cover. Biosig Technologies currently holds about 887 K in cash with (17.31 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.02.
Check Biosig Technologies Probability Of Bankruptcy
Ownership Allocation
Biosig Technologies retains a total of 11.2 Million outstanding shares. Biosig Technologies retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Remember, it does not matter who owns the company or if the company is currently losing money. If the true value of the company is more than the market pays for it currently, you can still have a good investment opportunity.
Check Biosig Ownership Details

Biosig Stock Price Odds Analysis

Contingent on a normal probability distribution, the odds of Biosig Technologies jumping above the current price in 90 days from now is about 33.55%. The Biosig Technologies probability density function shows the probability of Biosig Technologies stock to fall within a particular range of prices over 90 days. Given the investment horizon of 90 days the stock has a beta coefficient of 1.2945 suggesting as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Biosig Technologies will likely underperform. Additionally, biosig Technologies has an alpha of 0.4352, implying that it can generate a 0.44 percent excess return over NYSE Composite after adjusting for the inherited market risk (beta).
  Odds Below 1.41HorizonTargetOdds Above 1.41
66.39%90 days
 1.41 
33.55%
Based on a normal probability distribution, the odds of Biosig Technologies to move above the current price in 90 days from now is about 33.55 (This Biosig Technologies probability density function shows the probability of Biosig Stock to fall within a particular range of prices over 90 days) .

Biosig Stock Institutional Holders

Institutional Holdings refers to the ownership stake in Biosig Technologies that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Biosig Technologies' outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Biosig Technologies' value.
InstituionRecorded OnShares
Royal Bank Of Canada2023-09-30
47.6 K
Webster Bank, N. A.2023-12-31
40 K
Advisor Group Holdings, Inc.2023-09-30
32.5 K
Xtx Topco Ltd2023-09-30
31.3 K
Charles Schwab Investment Management Inc2023-09-30
30.1 K
Douglas Lane & Associates, Llc2023-12-31
29.8 K
Ae Wealth Management Llc2023-09-30
26.7 K
Global Wealth Management Investment Advisory, Inc.2023-09-30
26.7 K
Redwood Wealth Management Group Llc2023-12-31
23.3 K
Vanguard Group Inc2023-09-30
2.4 M
Blackrock Inc2023-09-30
595.1 K
View Biosig Technologies Diagnostics

Biosig Technologies Historical Income Statement

Biosig Technologies Income Statement is one of the three primary financial statements used for reporting Biosig's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Biosig Technologies revenue and expense. Biosig Technologies Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At this time, Biosig Technologies' Depreciation And Amortization is very stable compared to the past year. As of the 19th of April 2024, Research Development is likely to grow to about 5.9 M, while Selling General Administrative is likely to drop about 19.1 M. View More Fundamentals

Biosig Stock Against Markets

Picking the right benchmark for Biosig Technologies stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Biosig Technologies stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Biosig Technologies is critical whether you are bullish or bearish towards Biosig Technologies at a given time. Please also check how Biosig Technologies' historical prices are related to one of the top price index indicators.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Biosig Technologies without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Portfolio Suggestion Now

   

Portfolio Suggestion

Get suggestions outside of your existing asset allocation including your own model portfolios
All  Next Launch Module

Biosig Technologies Corporate Directors

Biosig Technologies corporate directors refer to members of a Biosig Technologies board of directors. The board of directors generally takes responsibility for the Biosig Technologies' affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Biosig Technologies' board members must vote for the resolution. The Biosig Technologies board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.
Samuel NavarroIndependent DirectorProfile
Olivier ChaudoirDirector of MarketingProfile
Andrew FillerDirectorProfile
David WeildDirectorProfile

How to buy Biosig Stock?

Before investing in Biosig Technologies, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Biosig Technologies. To buy Biosig Technologies stock, you can follow these steps:
  • Choose a brokerage firm: You need to select a brokerage firm to buy shares of Biosig Technologies. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
  • Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
  • Fund your account: You will need to deposit funds into your brokerage account to purchase Biosig Technologies stock. You can do this by transferring funds from your bank account or other investment accounts.
  • Place your order: Once you have located Biosig Technologies stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
  • Monitor your investment: After you have purchased Biosig Technologies stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Biosig Technologies, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. For more information on how to buy Biosig Stock please use our How to Invest in Biosig Technologies guide.

Already Invested in Biosig Technologies?

The danger of trading Biosig Technologies is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Biosig Technologies is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Biosig Technologies. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Biosig Technologies is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Biosig Technologies is a strong investment it is important to analyze Biosig Technologies' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Biosig Technologies' future performance. For an informed investment choice regarding Biosig Stock, refer to the following important reports:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biosig Technologies. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price.
To learn how to invest in Biosig Stock, please use our How to Invest in Biosig Technologies guide.
Note that the Biosig Technologies information on this page should be used as a complementary analysis to other Biosig Technologies' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.

Complementary Tools for Biosig Stock analysis

When running Biosig Technologies' price analysis, check to measure Biosig Technologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biosig Technologies is operating at the current time. Most of Biosig Technologies' value examination focuses on studying past and present price action to predict the probability of Biosig Technologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biosig Technologies' price. Additionally, you may evaluate how the addition of Biosig Technologies to your portfolios can decrease your overall portfolio volatility.
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Global Correlations
Find global opportunities by holding instruments from different markets
Is Biosig Technologies' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Biosig Technologies. If investors know Biosig will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Biosig Technologies listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(4.70)
Revenue Per Share
0.022
Quarterly Revenue Growth
(0.99)
Return On Assets
(4.49)
Return On Equity
(59.77)
The market value of Biosig Technologies is measured differently than its book value, which is the value of Biosig that is recorded on the company's balance sheet. Investors also form their own opinion of Biosig Technologies' value that differs from its market value or its book value, called intrinsic value, which is Biosig Technologies' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Biosig Technologies' market value can be influenced by many factors that don't directly affect Biosig Technologies' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Biosig Technologies' value and its price as these two are different measures arrived at by different means. Investors typically determine if Biosig Technologies is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Biosig Technologies' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.